Latest Period
Q2 2026
Security Snapshot
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) Institutional Ownership
CUSIP: 803607100
13F Institutional Holders and Ownership History from Q1 2014 to Q2 2026
Institutions Reporting
322
Shares (Excl. Options)
107,549,198
Price
$17.97
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Symbol
- SRPT on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 107,549,198
- Total 13F value
- $1,931,734,868
- Portfolio coverage rank
- 0%
- Share change
- +4,828,145
- Value change
- +$60,454,218
- Number of holders
- 322
- Shares outstanding
- 105,538,436
- SEC-reported price per share
- $18.38
- Insider filing price
- $18.38
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- SRPT - Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share is tracked under CUSIP 803607100.
- 322 institutions reported positions in Q2 2026.
- 7 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 343 to 322 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $2,233,541,093 to $1,931,734,868.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 322 institutions filings for Q2 2026.
Security key
803607100
Latest holder period
Q2 2026
13F holders
322
13D/G owners
7
CIK / CUSIP context first
Open Q2 2026 holders
SRPT full holder history
Sarepta Therapeutics, Inc. SEC filings
Sarepta Therapeutics, Inc. company facts
Sarepta Therapeutics, Inc. insider transactions
Sarepta Therapeutics, Inc. 13D/G history
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 803607100:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
7
Security
SRPT
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 16% | +25% | $299,067,881 | +$61,277,125 | 16,642,620 | +26% | BlackRock, Inc. | 30 Jun 2026 |
| STATE STREET CORP | 8.4% | +60% | $182,958,434 | +$74,101,742 | 8,916,103 | +68% | STATE STREET CORPORATION | 30 Jun 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 8% | +27% | $174,408,119 | +$35,874,152 | 8,499,421 | +26% | Vanguard Portfolio Management | 30 Jun 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.1% | $116,831,964 | 5,369,116 | Vanguard Capital Management | 31 Mar 2026 | |||
| AQR CAPITAL MANAGEMENT LLC | 5% | -34% | $109,365,259 | -$56,946,653 | 5,329,691 | -34% | AQR Capital Management, LLC | 30 Jun 2026 |
| D. E. SHAW & CO, L.P. | 1.9% | -64% | $38,675,372 | -$58,829,132 | 2,007,025 | -60% | D. E. Shaw & Co., L.P. | 30 Sep 2025 |
| Capital International Investors | 0.5% | -98% | $9,523,733 | -$152,120,639 | 524,146 | -94% | Capital International Investors | 30 Jun 2025 |
As of 30 Jun 2026, 322 institutional investors reported holding 107,549,198 shares of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT). This represents 102% of the company’s total 105,538,436 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
79%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 18% | 18,994,958 | +29% | 0.01% | $341,339,398 |
| STATE STREET CORP | 8.4% | 8,916,090 | +35% | 0% | $160,222,137 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 7.9% | 8,377,470 | +26% | 0.01% | $150,543,136 |
| TWO SIGMA INVESTMENTS, LP | 4.4% | 4,598,735 | +0.12% | 0.06% | $82,639,268 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.4% | 4,591,755 | +0.3% | 0% | $82,513,837 |
| FIRST TRUST ADVISORS LP | 4.1% | 4,365,951 | +5.6% | 0.05% | $78,456,086 |
| AQR CAPITAL MANAGEMENT LLC | 4.1% | 4,325,689 | -33% | 0.03% | $76,867,492 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.6% | 2,771,758 | +39% | 0% | $49,818,796 |
| Erste Asset Management GmbH | 2.4% | 2,568,945 | -13% | 0.35% | $45,513,625 |
| MARSHALL WACE, LLP | 2.1% | 2,206,022 | +204% | 0.03% | $39,642,216 |
| MORGAN STANLEY | 2.1% | 2,202,640 | -15% | 0% | $39,581,440 |
| Aberdeen Group plc | 2.1% | 2,194,948 | -5.3% | 0.06% | $39,443,216 |
| BANK OF AMERICA CORP /DE/ | 1.9% | 2,055,985 | -4.2% | 0% | $36,946,051 |
| GOLDMAN SACHS GROUP INC | 1.9% | 2,042,501 | +89% | 0% | $36,703,734 |
| UBS Group AG | 1.5% | 1,624,415 | -27% | 0% | $29,190,737 |
| FEDERATED HERMES, INC. | 1.5% | 1,590,331 | -11% | 0.04% | $28,578,248 |
| NORTHERN TRUST CORP | 1.1% | 1,210,732 | +67% | 0% | $21,756,855 |
| MILLENNIUM MANAGEMENT LLC | 1.1% | 1,193,468 | -2.3% | 0.01% | $21,446,620 |
| T. Rowe Price Investment Management, Inc. | 1.1% | 1,156,083 | +2% | 0.01% | $20,775,000 |
| CITIGROUP INC | 1.1% | 1,155,006 | +0.64% | 0.01% | $20,755,457 |
| RENAISSANCE TECHNOLOGIES LLC | 1.1% | 1,121,378 | -33% | 0.03% | $20,151,163 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.93% | 980,321 | +24% | 0% | $17,616,368 |
| Connor, Clark & Lunn Investment Management Ltd. | 0.92% | 973,493 | -4.6% | 0.03% | $17,493,669 |
| Invesco Ltd. | 0.86% | 903,379 | +120% | 0% | $16,233,721 |
| Legal & General Group Plc | 0.83% | 877,627 | +1.3% | 0% | $15,770,961 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
50
Latest
Q2 2026
Rows shown
1-25 of 50
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 107,549,198 | $1,931,734,868 | +$60,454,218 | $17.97 | 322 |
| 2026 Q1 | 102,931,447 | $2,233,541,093 | +$202,697,630 | $21.76 | 343 |
| 2025 Q4 | 93,387,853 | $2,009,593,627 | +$171,387,492 | $21.52 | 344 |
| 2025 Q3 | 86,798,814 | $1,674,545,829 | +$92,993,938 | $19.27 | 313 |
| 2025 Q2 | 82,768,888 | $1,414,059,003 | -$616,173,124 | $17.10 | 354 |
| 2025 Q1 | 85,664,154 | $5,483,381,207 | -$371,527,547 | $63.82 | 419 |
| 2024 Q4 | 87,843,903 | $10,682,091,570 | +$115,071,840 | $121.59 | 459 |
| 2024 Q3 | 86,796,388 | $10,834,992,283 | -$451,898,219 | $124.89 | 451 |
| 2024 Q2 | 88,782,224 | $14,026,709,174 | +$922,747,140 | $158.00 | 479 |
| 2024 Q1 | 83,236,471 | $10,771,794,424 | +$210,287,311 | $129.46 | 408 |
| 2023 Q4 | 81,574,475 | $7,866,654,991 | -$295,015,527 | $96.43 | 386 |
| 2023 Q3 | 83,265,476 | $10,092,124,857 | +$213,088,130 | $121.22 | 390 |
| 2023 Q2 | 81,723,093 | $9,359,752,457 | +$62,411,602 | $114.52 | 399 |
| 2023 Q1 | 81,211,200 | $11,191,507,838 | +$325,102,660 | $137.83 | 422 |
| 2022 Q4 | 78,931,000 | $10,227,280,074 | +$92,872,677 | $129.58 | 405 |
| 2022 Q3 | 78,254,620 | $8,650,122,111 | +$568,958,858 | $110.54 | 364 |
| 2022 Q2 | 73,313,897 | $5,496,320,989 | +$35,960,887 | $74.96 | 312 |
| 2022 Q1 | 73,015,967 | $5,705,221,328 | +$56,363,206 | $78.12 | 314 |
| 2021 Q4 | 71,894,248 | $6,474,592,585 | +$536,221,296 | $90.05 | 326 |
| 2021 Q3 | 65,753,485 | $6,079,879,477 | +$130,063,243 | $92.48 | 297 |
| 2021 Q2 | 64,801,548 | $5,037,256,042 | -$83,636,915 | $77.74 | 315 |
| 2021 Q1 | 66,263,834 | $4,936,320,529 | -$714,137,111 | $74.53 | 346 |
| 2020 Q4 | 70,628,202 | $12,036,993,873 | -$160,139,710 | $170.49 | 435 |
| 2020 Q3 | 72,104,327 | $10,123,672,605 | -$335,637,260 | $140.43 | 393 |
| 2020 Q2 | 73,863,151 | $11,844,121,308 | +$150,679,056 | $160.34 | 397 |